M Helle
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 10%
- HER2/EGFR in Cancer Research
Papers in
-
- Glycosylation and Glycoproteins Research 6
-
- Monoclonal and Polyclonal Antibodies Research 8
- Co-authors
- Jorma Isola (10 shared papers)Heikki J. Helin (7 shared papers)Olli Kallioniemi (4 shared papers)Kai Krohn (10 shared papers)Heikki Helin (7 shared papers)J. M. Koski (1 shared paper)Heikki Hermunen (1 shared paper)Ullamari Hakulinen (1 shared paper)
In The Last Decade
M Helle
30 papers receiving 644 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 193
- Oncology 251
- Pathology and Forensic Medicine 141
- Reproductive Medicine 59
- Rheumatology 89
Countries citing papers authored by M Helle
This map shows the geographic impact of M Helle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Helle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Helle more than expected).
Fields of papers citing papers by M Helle
This network shows the impact of papers produced by M Helle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Helle. The network helps show where M Helle may publish in the future.
Co-authors
The 25 scholars most cited alongside M Helle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 150 | |
| 2 | 2006 | 100 | |
| 3 | 1990 | 71 | |
| 4 | 1990 | 59 | |
| 5 | 1999 | 44 | |
| 6 | 1988 | 38 | |
| 7 | 2011 | 27 | |
| 8 | 1997 | 27 | |
| 9 | Proliferative activity and steroid receptors determined by immunohistochemistry in adjacent frozen sections of 102 breast carcinomas. | 1989 | 19 |
| 10 | 1990 | 16 | |
| 11 | Generation of monoclonal antibodies to human milk-fat globule membrane antigens, with special reference to a precipitable secretory product of breast and ovarian carcinomas. | 1985 | 13 |
| 12 | 1990 | 11 | |
| 13 | The use of radiolabelled monoclonal antibodies to human milk fat globule membrane antigens in antibody-guided tumour imaging, and administration of therapeutic dose of labelled antibody in wide-spread ovarian carcinoma. A preliminary report. | 1985 | 10 |
| 14 | 1986 | 9 | |
| 15 | 1988 | 9 | |
| 16 | 1988 | 8 | |
| 17 | 1989 | 7 | |
| 18 | 1996 | 7 | |
| 19 | 1992 | 6 | |
| 20 | 1990 | 6 |
About M Helle
M Helle is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Oncology, Genetics and Surgery, having authored 30 papers that have together received 676 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Estrogen and related hormone effects (7 papers), Glycosylation and Glycoproteins Research (6 papers), Bladder and Urothelial Cancer Treatments (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Breast Cancer Treatment Studies (2 papers) and Cell Adhesion Molecules Research (2 papers). The work is most often cited by research in Cancer Research (193 citations), Oncology (251 citations), Pathology and Forensic Medicine (141 citations), Reproductive Medicine (59 citations) and Rheumatology (89 citations). M Helle has collaborated with scholars based in Finland, Bahrain and Japan. Frequent co-authors include Jorma Isola, Heikki J. Helin, Olli Kallioniemi, Kai Krohn, Heikki Helin, J. M. Koski, Heikki Hermunen, Ullamari Hakulinen, Simo Saarakkala and Tapani Liukkonen. Their work appears in journals such as Cancer, British Journal of Cancer, Apmis, Journal of Clinical Pathology and American Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.